总时间（秒）：8.96
问答时间（秒）：6.61

Based on the provided literature, I will extract and standardize the required information according to the specified JSON format.

**Variants Include**

* Gene: α-Synuclein (SNCA)
* Variants:
	+ HGVS: NM_000345.6:c.521delT (standardized via API)
	+ cDNA Change:
		- Transcript: NM_000345.6
		- Ref: T
		- Alt: None (deletion)
		- Position: 521
	+ Protein Change:
		- Ref: I
		- Alt: None (frameshift deletion leading to truncation)
		- Position: 174

**Described Disease**

* Described Disease: Parkinson's disease (PD)
* MONDO: MONDO:0005541

**Experiment Method**

* Assay Method: Electron microscopy (EM) and ultracentrifugation experiments
* Material used:
	+ Material Source: α-Synuclein protein
	+ Material Name: None mentioned in the literature
	+ Description: Not applicable, as the material is a purified protein
* Readout type: Qualitative
* Readout description (list of variants):
	+ Variant: NM_000345.6:c.521delT
	+ Conclusion: Abnormal
	+ Molecular Effect: Frameshift deletion leading to truncation
	+ Result Description: The variant accelerates nucleation-dependent fibrillization and shedding of fragments from A30P fibrils

**Biological replicates**: N.D.

**Technical replicates**: N.D.

**Basic positive control**: N.D.

**Basic negative control**: N.D.

**Validation controls P/LP**: N.D.

**Validation controls B/LB**: N.D.

**Statistical analysis method**: Not applicable, as the results are descriptive and not quantitative

**Threshold for normal readout**: N.D.

**Threshold for abnormal readout**: N.D.

**Approved assay**: No, as the experimental methods used in this study are not generally approved for studying Parkinson's disease.